RecruitingNCT06807723

Further Delineation of the De Santo Shinawi Syndrome Phenotype Using a Series of Individuals Carrying a Pathogenic Variant of the WAC Gene


Sponsor

University Hospital, Clermont-Ferrand

Enrollment

50 participants

Start Date

Nov 7, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The aim of this retrospective, multicenter study would be to extend the phenotypic spectrum of DeSanto Shinawi Syndrome and improve the knowledge of its evolution. To this end, the investigators would like to issue a call for international collaboration in order to create a series of new genetically diagnosed patients, not yet described in previous publications, and with a larger number of individuals evaluated in a single study. One of the aims would be to establish a set of standardized clinical and paraclinical examinations to be carried out at diagnosis and for follow-up of affected patients. This would enable patients, their families and the caregivers involved to better anticipate future management.


Eligibility

Inclusion Criteria2

  • Children and adults of any age.
  • Molecular diagnosis of a pathogenic (or likely pathogenic) variant involving the WAC gene (SNV, CNV, SV).

Exclusion Criteria3

  • Patients with a molecular diagnosis of another VP (SNV) of a gene responsible for a neurodevelopmental disorder.
  • Patient having already participated in a DESSH study with published data.
  • No patient data available.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Clermont-Ferrand University Hospital

Clermont-Ferrand, Auvergne, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06807723


Related Trials